Peer Review History

Original SubmissionSeptember 23, 2022
Decision Letter - Nasser Hadal Alotaibi, Editor

PONE-D-22-26363The Impact of COVID-19 Pandemic on Key Performance Indicators in Three Saudi HospitalsPLOS ONE

Dear Dr. Alharbi,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Feb 22 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Nasser Hadal Alotaibi

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: 1. Table 1 Data Collection, in the sample size category, the author wrote 100% without stating the number of sample size? Does the 100% is referring to the sample size obtained? Best if the author can state the number of sample obtained in frequency too. The sample size obtained for the study is unclear. Is the bed capacity in the respective hospitals is your actual sample?

2. Table 3 Analysis of Variance; best if the author can limit the decimal point to the two decimal point for standardization in statistic. Please follow journal requirement. If it is not stated, two decimal point is best used to indicate the statistic results.

3. Paragraph for discussion (line 185 - 193) is not needed. Focus your discussion based on the result without stating facts that have been previously discussed earlier in the introduction section.

4. The paper is lacking in critical recommendation on the issue, while the author is pushing for proposed contingency plan? what kind of contingency plan that should be proposed for the pandemic? This might add value to the policy maker. Thus the conclusion seemed lacking in providing concrete ending to what should be done to prevent/ address the issue.

Reviewer #2: A well organized article. The ethical review for the research meets the required standards. The methods of statistical analysis used for the research were sound and the results of the 2 way ANOVA test supported the conclusion of the article. Enough data was provided in the article although it would have been easier to absorb/understand the provided data used for analysis (OPD waiting times in days and Elective OR utilization rates during Pre, early and post pandemic periods) if they were all included in a single table of data extraction. The sizes of figures 1-4 could be increased a bit to provide better visibility for the reader. The article was written intelligibly, with appropriate use of the English language although there unnecessary repetition of facts in the introduction and discussion sections eg ''To contain the spread of the COVID-19 disease, the Saudi government adopted the lockdown strategy''. Adequate explanation of the reasons for variation in the results/findings among the 3 hospitals were give in the discussion section with good interpretation of the findings. The limitations were addressed properly and the conclusion was brief and concise. In general, it was a very interesting and quite unique article as it aims to explore, compare and analyse the differences in pandemic effects on Key performance indicators in 3 hospitals providing very different types of medical care.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Mohd Redhuan Dzulkipli

Reviewer #2: Yes: Atinuke Hephzibah Adeyemo

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Response to Reviewers

Reviewer #1

Thank you so much for your valuable comments. Below are my responses for each point.

1. Table 1 Data Collection, in the sample size category, the author wrote 100% without stating the number of sample size? Does the 100% is referring to the sample size obtained? Best if the author can state the number of sample obtained in frequency too. The sample size obtained for the study is unclear. Is the bed capacity in the respective hospitals is your actual sample?

For our research, we used secondary data from Adaa’ program, collected to measure hospital quality metrics. This data did not report the exact sample size but did explain that for the OPD indicator, the data collectors used 100% of the patient’s data who used the OPD during the study period. Similarly, for the OR indicator, the data collectors used 100% of the patient’s data who used the OR during the study period. However, we added the visits numbers for the OPD and OR during the study three stages (pre-COVID, early-COVID, and post-COVID) in the supplement file appendix 1.

2. Table 3 Analysis of Variance; best if the author can limit the decimal point to the two decimal point for standardization in statistic. Please follow journal requirement. If it is not stated, two decimal point is best used to indicate the statistic results.

Corrected as advised.

3. Paragraph for discussion (line 185 - 193) is not needed. Focus your discussion based on the result without stating facts that have been previously discussed earlier in the introduction section.

Deleted as advised.

4. The paper is lacking in critical recommendation on the issue, while the author is pushing for proposed contingency plan? what kind of contingency plan that should be proposed for the pandemic? This might add value to the policy maker. Thus the conclusion seemed lacking in providing concrete ending to what should be done to prevent/ address the issue.

Recommendations has been added to the conclusion section (Lines 254-260)

Reviewer #2

A well organized article. The ethical review for the research meets the required standards. The methods of statistical analysis used for the research were sound and the results of the 2 way ANOVA test supported the conclusion of the article. Enough data was provided in the article although it would have been easier to absorb/understand the provided data used for analysis (OPD waiting times in days and Elective OR utilization rates during Pre, early and post pandemic periods) if they were all included in a single table of data extraction. The sizes of figures 1-4 could be increased a bit to provide better visibility for the reader. The article was written intelligibly, with appropriate use of the English language although there unnecessary repetition of facts in the introduction and discussion sections eg ''To contain the spread of the COVID-19 disease, the Saudi government adopted the lockdown strategy''. Adequate explanation of the reasons for variation in the results/findings among the 3 hospitals were give in the discussion section with good interpretation of the findings. The limitations were addressed properly and the conclusion was brief and concise. In general, it was a very interesting and quite unique article as it aims to explore, compare and analyse the differences in pandemic effects on Key performance indicators in 3 hospitals providing very different types of medical care.

Thank you so much for your valuable comments.

The data used for analysis (OPD waiting times in days and Elective OR utilization rates during Pre, early and post pandemic periods) were all included in a supplemental file.

The figures have been increased in size for better visibility.

Also, the unnecessary repetition of facts in the discussion section has been deleted.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Nasser Hadal Alotaibi, Editor

The Impact of COVID-19 Pandemic on Key Performance Indicators in Three Saudi Hospitals

PONE-D-22-26363R1

Dear Dr. Alharbi,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Nasser Hadal Alotaibi

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

Formally Accepted
Acceptance Letter - Nasser Hadal Alotaibi, Editor

PONE-D-22-26363R1

The Impact of COVID-19 Pandemic on Key Performance Indicators in Three Saudi Hospitals

Dear Dr. Alharbi:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Nasser Hadal Alotaibi

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .